Cape Verde vs Madagascar: Number of HIV positive pregnant women receiving antiretrovirals
Cape Verde
63
in 2011
Madagascar
106
in 2011
Cape Verde rank
35th
Madagascar rank
34th
Number of HIV positive pregnant women receiving antiretrovirals over time
- Cape Verde
- Madagascar
How they compare
Madagascar currently reports 106 against 63 in Cape Verde, a difference of 43.
That makes Madagascar's figure about 1.7 times Cape Verde's.
The two have swapped places 1 time across 5 shared years of data; in 2005 it was Cape Verde ahead.
Cape Verde ranks 35th and Madagascar ranks 34th of 38 countries.
Across the 2 decades both report, Cape Verde averaged higher in 1 and Madagascar in 1.
Head to head by decade
| Decade | Cape Verde | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.75 | 14.25 | 27.5 | Cape Verde |
| 2010s | 63 | 106 | 43 | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of hiv positive pregnant women receiving antiretrovirals, Cape Verde or Madagascar?
- Madagascar, at 106 against 63 in Cape Verde as of 2011.
- What is the difference in number of hiv positive pregnant women receiving antiretrovirals between Cape Verde and Madagascar?
- 43, with Madagascar ahead.
- How many years of comparable data are there for Cape Verde and Madagascar?
- 5 years are reported by both, from 2005 to 2011.
- How do Cape Verde and Madagascar rank globally for number of hiv positive pregnant women receiving antiretrovirals?
- Cape Verde ranks 35th and Madagascar ranks 34th of 38 countries.
- Where does this data come from?
- http://data.unaids.org/pub/GlobalReport/2008/, published as Number of HIV positive pregnant women receiving antiretrovirals. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV.